New Price for Muscular Dystrophy Drug Draws Criticism | NBC 5 Dallas-Fort Worth
National & International News
The day’s top national and international news

New Price for Muscular Dystrophy Drug Draws Criticism

In the spotlight is a steroid called deflazacort

    processing...

    NEWSLETTERS

    New Price for Muscular Dystrophy Drug Draws Criticism
    NBC 5 News

    Christine McSherry is used to a fight. Her son, Jett, was diagnosed with Duchenne muscular dystrophy, a rare, debilitating condition, when he was 5. He lost the ability to walk just before he turned 14.

    McSherry has become an outspoken advocate for Jett and other kids with Duchenne, particularly in fighting for access to drugs she's convinced help against the disease's devastating effects, CNBC reported.

    Jett, now 21, has been taking a steroid called deflazacort since he was 8. Deflazacort wasn't approved in the U.S., so McSherry and a number of other families of kids with Duchenne imported the drug from overseas. She says it cost about $1,200 a year out of pocket.

    On Monday, deflazacort got a new price tag: $35,000 a year for a patient in the U.S. weighing 25 kilograms, or about 55 pounds.

    Man Visits Disneyland 2,000 Times In a Row

    [NATL] Man Visits Disneyland 2,000 Times In a Row

    A Huntington Beach man has set a record for most consecutive visits to Disneyland. Jeff Reitz, 44, has visited the park 2,000 times in a row. Reitz started visiting the park every day when he was unemployed and wanted to keep his spirits up. Employed at the VA now, Reitz continues to visit every day after work because it helps him to decompress after a long day. His favorite ride is the Matterhorn Bobsleds, which he first rode with his mom when he was 2 years old. 

    (Published Friday, June 23, 2017)

    PTC Therapeutics, which set the price, says it "represents sustainable pricing which balances providing access to eligible patients in the United States…while maintaining sufficient infrastructure and programs including continued investment in Duchenne."